As of 2024-12-15, the EV/EBITDA ratio of BB Biotech AG (BION.SW) is 9.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BION.SW's latest enterprise value is 2,274.76 mil CHF. BION.SW's TTM EBITDA according to its financial statements is 232.91 mil CHF. Dividing these 2 quantities gives us the above BION.SW EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.6x - 9.0x | 7.2x |
| Forward P/E multiples | 7.5x - 10.0x | 9.0x |
| Fair Price | 18.63 - 37.13 | 29.14 |
| Upside | -48.5% - 2.7% | -19.4% |
| Date | EV/EBITDA |
| 2024-12-11 | 9.97 |
| 2024-12-10 | 10.14 |
| 2024-12-09 | 10.11 |
| 2024-12-06 | 10.15 |
| 2024-12-05 | 10.08 |
| 2024-12-04 | 10.06 |
| 2024-12-03 | 10.04 |
| 2024-12-02 | 10.10 |
| 2024-11-29 | 10.05 |
| 2024-11-28 | 10.05 |
| 2024-11-27 | 10.00 |
| 2024-11-26 | 10.04 |
| 2024-11-25 | 10.00 |
| 2024-11-22 | 9.79 |
| 2024-11-21 | 9.72 |
| 2024-11-20 | 9.72 |
| 2024-11-19 | 9.73 |
| 2024-11-18 | 9.80 |
| 2024-11-15 | 10.00 |
| 2024-11-14 | 10.29 |
| 2024-11-13 | 10.40 |
| 2024-11-12 | 10.46 |
| 2024-11-11 | 10.65 |
| 2024-11-08 | 10.56 |
| 2024-11-07 | 10.41 |
| 2024-11-06 | 10.08 |
| 2024-11-05 | 9.94 |
| 2024-11-04 | 9.93 |
| 2024-11-01 | 9.99 |
| 2024-10-31 | 9.85 |
| 2024-10-30 | 9.91 |
| 2024-10-29 | 9.89 |
| 2024-10-28 | 9.83 |
| 2024-10-25 | 9.71 |
| 2024-10-24 | 10.05 |
| 2024-10-23 | 10.06 |
| 2024-10-22 | 10.19 |
| 2024-10-21 | 10.15 |
| 2024-10-18 | 10.05 |
| 2024-10-17 | 9.99 |
| 2024-10-16 | 9.86 |
| 2024-10-15 | 9.83 |
| 2024-10-14 | 9.87 |
| 2024-10-11 | 9.85 |
| 2024-10-10 | 9.77 |
| 2024-10-09 | 9.75 |
| 2024-10-08 | 9.81 |
| 2024-10-07 | 9.73 |
| 2024-10-04 | 9.73 |
| 2024-10-03 | 9.66 |